ISPUB.com / IJD/7/2/9329
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Dermatology
  • Volume 7
  • Number 2

Original Article

Hepatitis C Virus serology in patients with lichen planus

C Udayashankar, A Nath, M D’Souza

Keywords

anti-hcv antibodies, hepatitis c virus, lichen planus

Citation

C Udayashankar, A Nath, M D’Souza. Hepatitis C Virus serology in patients with lichen planus. The Internet Journal of Dermatology. 2008 Volume 7 Number 2.

Abstract


Background: The pathogenic role of Hepatitis C virus in the causation of lichen planus remains controversial. While a number of studies form several centers across the world show an association between HCV and LP, a good number of studies have refuted such an association. Aims and objectives: To study the association between Hepatitis C Virus infection and lichen planus in our institution. Methods: Third generation ELISA (Innova HCV ELISA) for anti-HCV antibodies in the plasma/serum was performed in 40 consecutive cases of lichen planus (confirmed by clinical examinations and histopathology) and equal number of age- and gender-matched healthy volunteers from October 2001 to May 2003. Results: ELISA test for anti-HCV antibodies was negative in all 40 cases as well as in 40 control individuals. Conclusion: There was no association between Hepatitis C Virus infection and lichen planus in our population in South India.

 

Introduction

Lichen planus (LP) is a papulosquamous disorder characterized by pruritic, purple, polygonal, plain topped, papules occurring in the flexor aspects of the extremities with occasional nail (classically pterygium) and oral mucosal involvement. 1 The exact etiology of lichen planus remains elusive. Several pathogenic mechanisms like immunogenic, genetic, infective, metabolic and many others, with emphasis on interaction between endogenous-genetic-autoimmune and exogenous-environmental components such as drugs or infections have been proposed to play a role in the etiology of the disease. 2 The role of Hepatitis C virus (HCV) infection in the causation of lichen planus (LP) is controversial as many studies from around the world, 3 including several studies from various parts of India, have shown contradictory results. We conducted a study to look for an association between Hepatitis C Virus infection and lichen planus in our institution in Pondicherry.

Materials and methods

Third generation ELISA (Innova HCV ELISA) for anti-HCV antibodies in the plasma/serum was performed in 40 consecutive cases of LP (confirmed by clinical examinations and histopathology) and an equal number of age- and gender-matched healthy volunteers from October 2001 to May 2003.

Results

The mean age of cases and control groups were 32.1±10.7 years (range of 19-56 years) and 32±9.3 years (range of 20-54 years), respectively. Number of cases and controls in the different age groups showed no significant difference. There were 19 males and 21 females in both the groups. There were 32 cases of LP involving the skin only, 4 cases involving the skin and the oral mucosa, 3 cases involving the oral mucosa only, and one case of nail LP. ELISA test for anti-HCV antibodies was negative in all the LP patients as well as in all the healthy volunteers.

Discussion

Mokni et al 4 published the first report of LP associated with HCV infection. Subsequently, a number of studies claimed such a causal association between HCV infection and LP. 356 A number of studies, on the other hand, failed to show any association between HCV and LP. 37891011 Nagao et al 3 demonstrated the existence and replication (by RT-PCR) of HCV within oral LP lesions. Erkek et al 3 found that the detection rate of HCV-RNA was higher in the lesional skin compared to non-lesional skin in HCV-infected LP patients. Oral LP after treatment of HCV infection with IFN-, 1213 and subsidence of such lesions after stopping IFN therapy 13 have also been reported. The prevalence of HCV in LP patients shows wide geographic variations – 0% in England, 14 3.8-28.6% in France, 3 0-55% in USA, 37.8-62% in Japan, 3 and 4-65% in Italy 3 . The reason for such variability is not clear, but may be because of geographic variations or a genetic susceptibility.

From an epidemiological standpoint, the main studies describing a strong association with HCV have been conducted mostly in Japan, Italy and Spain, all areas with a high HCV endemicity. 15 Campisi et al 15 found that a weak association between oral LP and HCV infection may exist only in areas where HCV is endemic. In India, studies conducted in Calicut, 16 Kolkata, 10 New Delhi 10 have failed to demonstrate a statistically significant association between HCV and LP, whereas studies conducted in Hyderabad and Bangalore 10 have shown a significant association. We have not found any association between lichen planus and HCV infection in our tertiary care center in Pondicherry. Whether the absence or the presence of an association between HCV infection and LP in different parts of India is due to the varied prevalence of HCV infections in different parts of the country is difficult to emphasize, as no consistent association between high prevalence of HCV infection in the population and the occurrence of LP has been found in the Indian studies (Table 1).

Figure 1
Table 1: Association between HCV infection and LP compared with the prevalence of HCV infection in different parts of India

Very recently, Carrozzo and Gandolfo maintained that the substantial geographical heterogeneity could be partially explained by immunogenetic factors related to the population. 17 Thus, the role of HCV in LP could be postulated to be one of a triggering factor in suitable environmental, immunogenetic and geographic conditions. 17

References

1. Breathnach SM, Black MM. Lichen planus and lichenoid disorders. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology, 7th edn., Oxford: Blackwell Science 2004: 42.1-42.32.
2. Daoud MS and Pittelkow MR. Lichen planus. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Fitzpatrick’s Dermatology in General Medicine, 6th edn., NewYork: McGraw-Hill 2003: 463-477.
3. Nagao Y, Sata M. Hepatitis C virus and lichen planus. J Gastroenterol Hepatol 2004; 19: 1101-13.
4. Mokni M, Rybojad M, Puppin D Jr, Catala S, Venezia F, Djian R, Morel P. Lichen planus and hepatitis C virus. J Am Acad Dermatol 1991; 24: 792.
5. Nagao Y, Sata M, Fukuizumi K, Ryu F, Ueno T. High incidence of oral lichen planus in an HCV hyperendemic area. Gastroenterology 2000; 119: 882-3.
6. Lodi G, Giuliani M, Majorana A, Sardella A, Bez C, Demarosi F, Carrassi A. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 2004; 151: 1172-81.
7. Prabhu S, Pavithran K, Sobhanadevi G. Lichen planus and hepatitis c virus (HCV) - Is there an association? A serological study of 65 cases. Indian J Dermatol Venereol Leprol 2002; 68: 273-4.
8. Singh OP, Kanwar AJ. Lichen planus in India: an appraisal of 441 cases. Int J Dermatol 1976; 15: 752-6.
9. Grote M, Reichart PA, Hopf U. Increased occurrence of oral lichen planus in hepatitis C infection. Mund Kiefer Gesichtschir 1999; 3: 30-3.
10. Das A, Das J, Majumdar G, Bhattacharya N, Neogi DK, Saha B. No association between seropositivity for Hepatitis C virus and lichen planus: A case control study. Indian J Dermatol Venereol Leprol 2006; 72: 198-200.
11. Rahnama Z, Esfandiarpour I, Farajzadeh S. The relationship between lichen planus and hepatitis C in dermatology outpatients in Kerman, Iran. Int J Dermatol 2005; 44: 746-8.
12. Sugiyama T, Shimizu M, Ohnishi H, Noguchi N, Iwata K, Kojima Y, Watanabe Y, Kawase K, Fukutomi Y, Yamauchi O, Yasuda S, Yamada M, Kobayashi S, Kojima M. Clinical evaluation in oral lichen planus with chronic hepatitis C: the role of interferon treatment. Nippon Shokakibyo Gakkai Zasshi 2000; 97: 568-74.
13. Nagao Y, Sata M, Suzuki H, Kameyama T, Ueno T. Histological improvement of oral Lichen planus in patients with chronic hepatitis C treated with interferon. Gastroenterology 1999; 117: 283-4.
14. Tucker SC, Coulson IH. Lichen planus is not associated with hepatitis C virus infection in patients from north west England. Acta Derm Venereol 1999; 79: 378-9.
15. Campisi G, Fedele S, Lo Russo L, Di Fede O, Aricò P, Craxì A, Mignogna MD. HCV infection and oral lichen planus: a weak association when HCV is endemic. J Viral Hepat 2004; 11: 465-70.
16. Prabhu S, Pavithran K, Sobhanadevi G. Lichen planus and hepatitis c virus (HCV) - Is there an association? A serological study of 65 cases. Indian J Dermatol Venereol Leprol 2002; 68: 273-4.
17. Carrozzo M, Gandolfo S. Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med 2003; 14: 115–127.
18. Irshad M, Agarwal SK. HCV infection in Delhi, India. Hepatology Research 1998; 11: 129-132.
19. Khaja MN, Munpally SK, Hussain MM, Habeebullah CM. Hepatitis C virus: The Indian scenario. Current Science 2002; 83: 219-224.
20. Sandesh K, Varghese T, Harikumar R, Beena P, Sasidharan VP, Bindu CS, Tony J, Harish K, Sunilkumar K, Ramachandran TM. Prevalence of Hepatitis B and C in the normal population and high risk groups in north Kerala. Trop Gastroenterol 2006; 27: 80-3.
21. Bhattacharya S, Badrinath S, Hamide A, Sujatha S. Seroprevalence of hepatitis C virus in a hospital based general population in South India. Indian J Med Microbiol 2003; 21: 43-5.

Author Information

C Udayashankar, MD
Ex-Junior Resident, Department of Dermatology and STD, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India.

Amiya Kumar Nath, MD
Senior Resident, Department of Dermatology and STD, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India.

Mariette D’Souza, MD
Professor, Department of Dermatology and STD, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India.

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy